[Bioavailability and analgetic effect of sustained-release ketobemidone capsules in patients with chronic pain of cancer].
Kjaer
M
M
Onkologisk afdeling, Aalborg Sygehus Syd.
Nielsen
H
H
Andersen
L S
LS
D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001682:Biological Availability; D002214:Capsules; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008614:Meperidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology
D000701:Analgesics, Opioid; D002214:Capsules; D003692:Delayed-Action Preparations; D008614:Meperidine; C012394:ketobemidone
Biotilgaengelighed og analgetisk effekt af sustained release ketobemidonkapsler hos cancerpatienter med kroniske smerter.